Dr. Ilya Gorbachinsky, MD

Dr. Gorbachinsky practices at Las Vegas Urology in Henderson, Nevada.

Dr. Gorbachinsky's NPI, 1588959977, was assigned on June 14, 2011. Dr. Gorbachinsky graduated from Wake Forest School of Medicine in 2010. Dr. Gorbachinsky holds Nevada license 16508.

Dr. Gorbachinsky's primary practice is Las Vegas Urology, at 2310 Corporate Cir, Henderson, NV 89074 in Clark County. The practice phone is (702) 385-4342.

Dr. Gorbachinsky's primary practice is Las Vegas Urology in Henderson, Nevada. Dr. Gorbachinsky is also affiliated with Dignity Health - Saint Rose Dominican Hospital, Siena Campus. The medical group on file is Las Vegas Urology. Dmand AI also links Dr. Gorbachinsky to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gorbachinsky practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Gorbachinsky's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Gorbachinsky is board certified in urology by the American Board of Urology. Dmand AI has Dr. Gorbachinsky's licenses on file in 2 states: Nevada and North Carolina.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Gorbachinsky treats.

CMS data shows 2,979 Medicare services from Dr. Gorbachinsky across 21 procedure codes in 2024, for 489 Medicare patients. Medicare paid $134,815 for them.

CMS counts 489 Medicare patients who saw Dr. Gorbachinsky in 2024. The largest group is 75 to 84, with 214 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gorbachinsky's median patient age at 70, with 25% women.

In 2024, Dr. Gorbachinsky wrote 1,399 Medicare Part D claims for 502 patients. 91% of them were for generic drugs. CMS names the drug for 1,257 of them, across 21 drugs with 11 or more claims each, at $244,488 in total drug cost. In 2023, CMS named 1,186 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Gorbachinsky for performance year 2024, reported as part of a group. Dr. Gorbachinsky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gorbachinsky as offering telehealth. CMS counts 21 procedures of prostate resection by Dr. Gorbachinsky, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 14 papers to Dr. Gorbachinsky, published from 2011 to 2016. 2011 was the busiest year, with 3. Dr. Gorbachinsky's most frequent co-authors are Steve James Hodges, MD, Michael Thomas Freehill, MD and Kyle Wood.

CMS Open Payments shows 592 general payments to Dr. Gorbachinsky from 52 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. Valeant Pharmaceuticals International paid the most, $4,314.

Dr. Gorbachinsky graduated from Wake Forest School of Medicine in 2010. Dr. Gorbachinsky is a member of AUA.

Dr. Gorbachinsky is in network with 12 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.